Impairment of AKT3, a member of the AKT protein family, has also been linked to multiple myeloma, and mutations in the AKT3 gene have been frequently reported in de novo Philadelphia chromosome-positive AML. This evidence concerns the gene AKT1 and AL amyloidosis.